BackCigna Overview

Cigna EBIT

Cigna's EBIT is $9.6B, below the Finance sector average of $47T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$2.43B
↑ 29.29% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

$9.55B
↑ 12.47% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Cigna (CGN.DE) FAQ

The latest EBIT for CGN.DE is $9.6B as of September 2026. That compares with $8.5B in the prior-year period — up 12.5% year over year. That is below the Finance sector average of $47T. Investors often review this figure alongside Cigna's historical trend and sector peers before judging valuation or financial health.

Over the past year, CGN.DE's EBIT moved from $8.5B to $9.6B — a 12.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cigna's operating scale or balance-sheet position.

Against Finance companies, CGN.DE currently prints $9.6B for EBIT, while the sector average sits near $47T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Cigna's growth, margins, and balance sheet.

A EBIT figure of $9.6B for CGN.DE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $47T. Explore the charts below for those layers of context.

After noting CGN.DE's EBIT ($9.6B), review year-over-year change from $8.5B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.